endostatin
Showing 1 - 6 of 6
Non Small Cell Lung Cancer, Endostatin Trial in Guangzhou (Endostatin)
Not yet recruiting
- Non Small Cell Lung Cancer
- Endostatin
- Endostatin
-
Guangzhou, Guangdong, ChinaAffiliated Cancer Hospital and Institute of Guangzhou Medical Un
Jul 4, 2022
Advanced Solid Tumor, Refractory Tumor Trial in Suzhou (Radiotherapy, PD-1/PD-L1 inhibitor, Granulocyte-macrophage
Recruiting
- Advanced Solid Tumor
- Refractory Tumor
- Radiotherapy
- +4 more
-
Suzhou, ChinaThe Second Affiliated Hospital of SchoowUniversity
Sep 14, 2023
Vestibular Schwannoma, Neurofibromatosis Type 2 Trial in Beijing (Endostatin)
Completed
- Vestibular Schwannoma
- Neurofibromatosis Type 2
- Endostatin
-
Beijing, Beijing, ChinaBeijing Tiantan Hospital Affiliated to Capital Medical Universit
Feb 7, 2017
Non Small Cell Lung Cancer Trial in Tianjin (Endostatin, Vinorelbine, Cisplatin)
Completed
- Non Small Cell Lung Cancer
- Endostatin
- +2 more
-
Tianjin, Tianjin, ChinaTianjin Medical University Cancer Institute and Hospital
Jul 13, 2015
Nasopharyngeal Carcinoma Trial in Hangzhou (endostatin)
Unknown status
- Nasopharyngeal Carcinoma
- endostatin
-
Hangzhou, Zhejiang, ChinaZhejiang cancer hospital
Feb 16, 2014
NSCLC Trial in Guangzhou (Endostatin)
Unknown status
- Non-small Cell Lung Cancer
- Endostatin
-
Guangzhou, Guangdong, ChinaSun Yat-Sen University Cancer Center
Sep 17, 2012